Carrasco Dario I, Bahr Ben A, Seburn Kevin L, Pinter Martin J
Department of Physiology, Emory University, Atlanta, GA, USA.
Biotechnology Research and Training Center, University of North Carolina at Pembroke, Pembroke, NC, USA.
Exp Neurol. 2016 Apr;278:116-26. doi: 10.1016/j.expneurol.2016.02.002. Epub 2016 Feb 4.
In several animal models of motor neuron disease, degeneration begins in the periphery. Clarifying the possible role of Schwann cells remains a priority. We recently showed that terminal Schwann cells (TSCs) exhibit abnormalities in postnatal mice that express mutations of the SOD1 enzyme found in inherited human motor neuron disease. TSC abnormalities appeared before disease-related denervation commenced and the extent of TSC abnormality at P30 correlated with the extent of subsequent denervation. Denervated neuromuscular junctions (NMJs) were also observed that lacked any labeling for TSCs. This suggested that SOD1 TSCs may respond differently than wildtype TSCs to denervation which remain at denervated NMJs for several months. In the present study, the response of SOD1 TSCs to experimental denervation was examined. At P30 and P60, SC-specific S100 labeling was quickly lost from SOD1 NMJs and from preterminal regions. Evidence indicates that this loss eventually becomes complete at most SOD1 NMJs before reinnervation occurs. The loss of labeling was not specific for S100 and did not depend on loss of activity. Although some post-denervation labeling loss occurred at wildtype NMJs, this loss was never complete. Soon after denervation, large cells appeared near SOD1 NMJ bands which colabeled for SC markers as well as for activated caspase-3 suggesting that distal SOD1 SCs may experience cell death following denervation. Denervated SOD1 NMJs viewed 7 days after denervation with the electron microscope confirmed the absence of TSCs overlying endplates. These observations demonstrate that SOD1 TSCs and distal SCs respond abnormally to denervation. This behavior can be expected to hinder reinnervation and raises further questions concerning the ability of SOD1 TSCs to support normal functioning of motor terminals.
在几种运动神经元疾病的动物模型中,退化始于外周。阐明雪旺细胞可能发挥的作用仍是当务之急。我们最近发现,在出生后表达遗传性人类运动神经元疾病中发现的超氧化物歧化酶1(SOD1)酶突变的小鼠中,终末雪旺细胞(TSC)出现异常。TSC异常在与疾病相关的去神经支配开始之前就已出现,并且在P30时TSC异常的程度与随后去神经支配的程度相关。还观察到失神经的神经肌肉接头(NMJ)缺乏任何TSC标记。这表明SOD1 TSC对去神经支配的反应可能与野生型TSC不同,野生型TSC在失神经的NMJ处会停留数月。在本研究中,研究了SOD1 TSC对实验性去神经支配的反应。在P30和P60时,SOD1 NMJ和终末前区域的雪旺细胞特异性S100标记迅速消失。有证据表明,在重新神经支配发生之前,这种标记的丢失最终在大多数SOD1 NMJ处变得完全。标记的丢失并非S100所特有,也不依赖于活性的丧失。虽然野生型NMJ在去神经支配后也出现了一些标记丢失,但这种丢失从未完全。去神经支配后不久,在SOD1 NMJ带附近出现了大细胞,这些细胞同时标记了雪旺细胞标记物和活化的半胱天冬酶-3,这表明远端SOD1雪旺细胞在去神经支配后可能会经历细胞死亡。去神经支配7天后用电子显微镜观察失神经的SOD1 NMJ,证实终板上方没有TSC。这些观察结果表明,SOD1 TSC和远端雪旺细胞对去神经支配反应异常。可以预期这种行为会阻碍重新神经支配,并引发关于SOD1 TSC支持运动终末正常功能能力的进一步问题。